TFAP2E and gastric cancer: Given the usefulness of AP-2ε in chemotherapy, the DNA methyltransferase inhibitors (such as decitabine encapsulated in nanoparticles) have been employed to ameliorate chemoresistance in GC via enhanced demethylating activity towards TFAP2E and subsequent re-expression [23,24].